Usefulness of bronchial washing fluid for detection of EGFR mutations in non-small cell lung cancer

  • Ryu, Woo Kyung
  • Yong, Seung Hyun
  • Lee, Sang Hoon
  • Gwon, Hye Ran
  • Kim, Hye Ryun
  • 외 6명
Citations

WEB OF SCIENCE

4
Citations

SCOPUS

4

초록

Introduction: The implementation of bronchial washing fluid (BWF) as a diagnostic specimen may complement the low diagnostic yields of plasma in detecting EGFR mutation (mEGFR) in non-small cell lung cancer. However, the diagnostic value of BWF in detecting mEGFR has yet to be clarified.Materials and Methods: From March 2021 to August 2022, patients with histologically confirmed NSCLC with matched tumor tissue, BWF, and/or plasma samples were enrolled. Patients were classified into either initial diagnosis or rebiopsy groups. Diagnostic yields of mEGFR in BWF and plasma were evaluated using droplet digital polymerase chain reaction and compared to mEGFR in tumor tissue as standard.Results: The study included 123 patients (74.1 %) in the initial diagnosis and 43 patients (25.9 %) in the rebiopsy group. BWF showed higher sensitivity, specificity, and concordance rates than plasma in both the initial diagnosis (57.4 %, 96.4 %, and 74.0 % vs. 16.4 %, 96.2 %, and 53.1 %) and the rebiopsy group (87.9 %, 60.0 %, and 81.4 % vs. 25.0 %, 75.0 %, and 41.7 %). In the initial diagnosis group, mEGFR was detected in the BWF of 13 out of 16 patients, even in the absence of tumor cells in the tissue biopsy. In these cases, EGFR test results obtained from BWF showed concordance with EGFR test results from the tumor tissue obtained through repeated biopsy or surgery later. In the rebiopsy group, T790M was detected in 16 patients (37.2 %) by tissue biopsy. The combined use of tissue biopsy and BWF increased detection, confirming T790M in 22 patients (51.2 %).Discussion: The detection of mEGFR using BWF shows higher diagnostic yields than plasma for both initial diagnosis and rebiopsy. T790M was detected earlier in BWF than in tissue rebiopsy in some cases, providing patients with an early opportunity to access third-generation EGFR-TKIs. The complementary use of BWF with tumor tissue may improve precision in EGFR-mutated NSCLC treatment strategies.

키워드

Bronchial washing fluidDroplet digital polymerase chain reactionEpidermal growth factor receptor mutationEGFR T790MNon-small cell lung cancerBRONCHOALVEOLAR LAVAGE FLUIDOSIMERTINIBMANAGEMENTPLASMACTDNAPCR
제목
Usefulness of bronchial washing fluid for detection of EGFR mutations in non-small cell lung cancer
저자
Ryu, Woo KyungYong, Seung HyunLee, Sang HoonGwon, Hye RanKim, Hye RyunHong, Min HeeOh, Go EunJung, SeheeKim, Chi YoungChang, Yoon SooKim, Eun Young
DOI
10.1016/j.lungcan.2023.107390
발행일
2023-12
유형
Article
저널명
Lung Cancer
186